Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NSB | Ann: Quarterly Activities/Appendix 4C Cash Flow Report | 22/04/24 | 28 | 8.7K | |||
|
|||||||
NSB | Ann: Appointment of Executive Director & FDA Pre-Ind Meeting | 19/04/24 | 28 | 6.9K | |||
|
|||||||
NSB | emtinb close to glaucoma nerve cure | 19/04/24 | 1 | 376 | |||
|
|||||||
NSB | Ann: Notification of cessation of securities - NSB | 08/04/24 | 0 | 226 | |||
|
|||||||
NSB | Ann: Half Yearly Report and Accounts | 07/04/24 | 23 | 4.2K | |||
|
|||||||
NSB | Ann: NSB Receives A$2.2M Research & Development Tax Refund | 21:11 | 15 | 3.8K | |||
|
|||||||
NSB | Ann: Company Secretary Appointment/Resignation | 09/02/24 | 2 | 1.1K | |||
|
|||||||
NSB | Ann: Notification of cessation of securities - NSB | 15/01/24 | 0 | 346 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |